Body Mass Index as a Prognostic Marker in Glioblastoma Multiforme: A Clinical Outcome.

Purpose: Correlation of body mass index (BMI) with clinical outcome in patients with glioblastoma is not well documented. Hence, we studied the association between survival and pretreatment BMI in glioblastoma patients.

Methods And Materials: In this retrospective study, only patients with histopathology-confirmed glioblastoma were included.